Standout Papers

Trypan Blue Exclusion Test of Cel... 1995 2026 2005 2015 1.7k
  1. Trypan Blue Exclusion Test of Cell Viability (2015)
    Warren Strober Current Protocols in Immunology
  2. The immunological and genetic basis of inflammatory bowel disease (2003)
    Gerd Bouma, Warren Strober Nature reviews. Immunology
  3. Cell Contact–Dependent Immunosuppression by Cd4+Cd25+Regulatory T Cells Is Mediated by Cell Surface–Bound Transforming Growth Factor β (2001)
    Kazuhiko Nakamura, Atsushi Kitani et al. The Journal of Experimental Medicine
  4. Antibodies to interleukin 12 abrogate established experimental colitis in mice. (1995)
    MF Neurath, Ivan J. Fuss et al. The Journal of Experimental Medicine
  5. Dominant interfering fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome (1995)
    Galen H. Fisher, Stephen E. Straus et al. Cell
  6. Trypan Blue Exclusion Test of Cell Viability (1997)
    Warren Strober Current Protocols in Immunology
  7. The Immunology of Mucosal Models of Inflammation (2002)
    Warren Strober, Ivan J. Fuss et al. Annual Review of Immunology
  8. The fundamental basis of inflammatory bowel disease (2007)
    Warren Strober, Ivan J. Fuss et al. Journal of Clinical Investigation
  9. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn’s disease LP cells manifest increased secretion of IFN-γ, whereas ulcerative colitis LP cells manifest increased secretion of IL-5 (1996)
    Ivan J. Fuss, Markus F. Neurath et al. The Journal of Immunology
  10. Proinflammatory Cytokines in the Pathogenesis of Inflammatory Bowel Diseases (2011)
    Warren Strober, Ivan J. Fuss Gastroenterology
  11. Interleukin-13 Is the Key Effector Th2 Cytokine in Ulcerative Colitis That Affects Epithelial Tight Junctions, Apoptosis, and Cell Restitution (2005)
    Frank Heller, Peter Florian et al. Gastroenterology
  12. Local administration of antisense phosphorothiate olignucleotides to the p65 subunit of NF–κB abrogates established experimental colitis in mice (1996)
    Markus F. Neurath, Sven Pettersson et al. Nature Medicine
  13. IL-13 signaling through the IL-13α2 receptor is involved in induction of TGF-β1 production and fibrosis (2005)
    Stefan Fichtner‐Feigl, Warren Strober et al. Nature Medicine
  14. NOD2 is a negative regulator of Toll-like receptor 2–mediated T helper type 1 responses (2004)
    Tomohiro Watanabe, Atsushi Kitani et al. Nature Immunology
  15. Signalling pathways and molecular interactions of NOD1 and NOD2 (2005)
    Warren Strober, Peter J. Murray et al. Nature reviews. Immunology
  16. Anti–Interleukin-12 Antibody for Active Crohn's Disease (2004)
    Peter Mannon, Ivan J. Fuss et al. New England Journal of Medicine
  17. Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis (2004)
    Ivan J. Fuss, Frank Heller et al. Journal of Clinical Investigation
  18. Cutting Edge: Regulatory T Cells Induce CD4+CD25−Foxp3− T Cells or Are Self-Induced to Become Th17 Cells in the Absence of Exogenous TGF-β (2007)
    Lili Xu, Atsushi Kitani et al. The Journal of Immunology
  19. ROLE OF SUPPRESSOR T CELLS IN PATHOGENESIS OF COMMON VARIABLE HYPOGAMMAGLOBULINÆMIA (1974)
    Thomas A. Waldmann, S Broder et al. The Lancet
  20. Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. (1998)
    Frederick G. Hayden, Roschelle Fritz et al. Journal of Clinical Investigation
  21. The metabolism of low density lipoprotein in familial type II hyperlipoproteinemia (1972)
    Terry Langer, Warren Strober et al. Journal of Clinical Investigation
  22. TGF-β1 Plays an Important Role in the Mechanism of CD4+CD25+ Regulatory T Cell Activity in Both Humans and Mice (2004)
    Kazuhiko Nakamura, Atsushi Kitani et al. The Journal of Immunology
  23. Oxazolone Colitis, a Th2 Colitis Model Resembling Ulcerative Colitis, Is Mediated by IL-13-Producing NK-T Cells (2002)
    Frank Heller, Ivan J. Fuss et al. Immunity
  24. Experimental Models of Inflammatory Bowel Diseases (2015)
    Patricia Kiesler, Ivan J. Fuss et al. Cellular and Molecular Gastroenterology and Hepatology

Immediate Impact

10 by Nobel laureates 51 from Science/Nature 135 standout
Sub-graph 1 of 16

Citing Papers

Homeostatic mini-intestines through scaffold-guided organoid morphogenesis
2020 StandoutNature
Pathway paradigms revealed from the genetics of inflammatory bowel disease
2020 StandoutNature
84 intermediate papers

Works of Warren Strober being referenced

An increase in LRRK2 suppresses autophagy and enhances Dectin-1–induced immunity in a mouse model of colitis
2018
A Mutation in the Nlrp3 Gene Causing Inflammasome Hyperactivation Potentiates Th17 Cell-Dominant Immune Responses
2009
and 60 more

Author Peers

Author Last Decade Papers Cites
Warren Strober 26036 10858 7855 11444 430 48.8k
Markus F. Neurath 21948 16206 9101 13964 902 55.3k
Diane Mathis 32187 9833 4178 13349 380 50.8k
Charles A. Janeway 39308 4906 5560 11187 401 54.3k
Alain Fischer 25485 9525 6860 14111 702 45.9k
Yoichiro Iwakura 32339 3854 8560 17870 689 60.5k
Jeffrey A. Bluestone 47087 14135 3868 11046 494 67.9k
Jean‐Laurent Casanova 26385 8574 12317 7929 631 42.5k
Laurie H. Glimcher 23175 3517 8887 12973 234 44.8k
Fiona Powrie 28839 6819 3581 7563 170 39.3k
Leo A. B. Joosten 26609 4187 8294 16550 686 50.5k

All Works

Loading papers...

Rankless by CCL
2026